S100P and pancreatic neoplasm: Ectopic expression of S100P in pancreatic cancer results in higher tumor growth and metastasis, while the stable silencing results in reduced tumor growth, secondary metastasis and improved sensitivity of cancer cells towards chemotherapy [52, 53].